PHarmaceutical tech@2x
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Next-generation cell therapies: Be Bio raises $52m to develop B cell medicines
    • Covid recovery demands bigger thinking – leading macroeconomic influencers
    • Politicising the pandemic: what are the consequences of Trump’s rhetoric?

    Most Recent

    Digital Disruption

    Next-generation cell therapies: Be Bio raises $52m to develop B cell medicines

    29 Oct 2020
  • Investment

    Most Read

    • The relationship between FDI and international trade
    • What is FDI?
    • Why BEPS is a taxing matter for MNCs

    Most Recent

    The relationship between FDI and international trade

    30 Sep 2020
  • Sectors

    Sections

    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
      • Respiratory

    Most Read

    • Replace GxP SFTP/file servers with modern solutions for validated environments
    • Covid-19 vaccine: one of the most important and divisive healthcare issues in the upcoming US presidential election
    • GlobalData Epidemiologist Report: Global Covid cases pass 44.5 million – more than 1.1 million deaths

    Most Recent

    Big Data

    Replace GxP SFTP/file servers with modern solutions for validated environments

    29 Oct 2020
  • Deals

    Most Read

    • CStone and LegoChem to jointly develop novel antibody drug conjugate
    • Novartis and Molecular Partners collaborate on anti-Covid-19 programme
    • Next-generation cell therapies: Be Bio raises $52m to develop B cell medicines

    Most Recent

    deal

    CStone and LegoChem to jointly develop novel antibody drug conjugate

    29 Oct 2020
  • US Election

    Most Read

    • Politicising the pandemic: what are the consequences of Trump’s rhetoric?
    • US election: where do the candidates stand on non-Covid healthcare issues?
    • US election: where do the candidates stand on Covid-19 response?

    Most Recent

    Regulation

    Politicising the pandemic: what are the consequences of Trump’s rhetoric?

    28 Oct 2020
  • Companies

    Sections

    • Company A-Z
    • Product & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • STERISYS
    • Castium
    • Nipro PharmaPackaging

    Most Recent

    Drug Development

    STERISYS

    28 Oct 2020
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Supply Chain
    • Drug Development
    • Manufacturing
    • Diseases
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Diseases
      • Oncology
  • Deals
  • US Election
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Powder Handling
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Reports
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register

Daiichi Sankyo transfers 41 products to Alfresa Pharma

Daiichi Sankyo has revealed plans to split off and transfer its inventories to Alfresa Pharma, along...

1 August 2018

Latest News

deal

CStone and LegoChem to jointly develop novel antibody drug conjugate

29 Oct 2020
Infectious Diseases

Novartis and Molecular Partners collaborate on anti-Covid-19 programme

29 Oct 2020
Infectious Diseases

Lilly enters $375m bamlanivimab vials supply deal with US for Covid-19

29 Oct 2020
deal

Apellis enters drug development and commercialisation deal with Sobi

28 Oct 2020

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
logo-horizontal

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms & Conditions
  • Privacy Policy

© Copyright 2020 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more